HETEROGENEITY AND REMODELING OF THE MUCOSA IN THE PERITUMORAL ZONE OF COLORECTAL CANCER: A COMPREHENSIVE QUANTITATIVE MORPHOMETRIC ASSESSMENT

Main Article Content

Oleg Ivanovich Bondarev
Sergey Nikolaevich Filimonov
Pavel Alekseevich Azarov
Arnold Michailovich Surkov
Aleksey Grigoryevich Korotkevitch

Abstract

This study presents a comprehensive quantitative morphometric assessment of the colonic mucosa in the peritumoral zone (10-15 cm from the tumor margin) in patients with colorectal cancer (CRC). The analysis included 91 biopsy specimens: 41 from patients with endoscopically and histologically normal mucosa (control group) and 50 from the peritumoral zone of CRC patients.
Aim – to perform a comprehensive morphometric characterization of the mucosa in the peritumoral zone of colorectal cancer (CRC) to identify quantitative criteria of "field cancerization".
Materials and Methods. A retrospective analysis was conducted on 91 colonic mucosal biopsy specimens. Group 1 (control, n = 41) consisted of biopsies from patients with endoscopically and histologically normal mucosa. Group 2 (peritumoral zone in CRC, n = 50) included biopsies taken 10-15 cm from the macroscopic tumor margin of adenocarcinoma. Morphometric analysis was performed using an Olympus CX31 microscope and Biovision-4 software, assessing mucosal thickness, crypt density, and stroma-to-epithelium ratio.
Results. Mucosal thickness in the peritumoral zone was significantly reduced – 210.33 [185.50; 240.75] vs 245.13 [235.20; 258.45] µm in controls (p = 0.0004). The coefficient of variation of thickness increased 3.1-fold (22.40% vs 7.15%), indicating marked mucosal architectural heterogeneity. Crypt density decreased from 32.5 [30.1; 34.8] to 25.2 [21.0; 30.5] crypts/mm² (p < 0.001), while the stroma-to-epithelium ratio rose from 45.1 [42.3; 48.5] to 58.7 [51.2; 65.4] % (p < 0.001).
Conclusion. The identified morphometric alterations provide evidence of a «field of cancerization» in the peritumoral zone of CRC and may serve as an additional diagnostic criterion for planning the extent of surgical resection.

Keywords

colorectal cancer, peritumoral zone, morphometry, field cancerization, mucosa

Author Biographies

Oleg Ivanovich Bondarev,

MD, PhD, head of the research laboratory for pathological anatomy

Sergey Nikolaevich Filimonov,

doctor of medical sciences, professor, head of the department of human ecology, public health and healthcare; professor of the therapy department

Pavel Alekseevich Azarov,

candidate of medical sciences, assistant of the department of pathological anatomy and forensic medicine

Arnold Michailovich Surkov,

assistant of the department of pathological anatomy and forensic medicine

Aleksey Grigoryevich Korotkevitch,

doctor of medical sciences, professor, head of the department of surgery, urology, endoscopy, and pediatric surgery

Article Details

Information about financing and conflict of interests

The study had no sponsorship.
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.

How to Cite

Bondarev, O. I., Filimonov, S. N., Azarov, P. A., Surkov, A. M., & Korotkevitch, A. G. (2026). HETEROGENEITY AND REMODELING OF THE MUCOSA IN THE PERITUMORAL ZONE OF COLORECTAL CANCER: A COMPREHENSIVE QUANTITATIVE MORPHOMETRIC ASSESSMENT. Medicine in Kuzbass, 25(1), 15-21. https://doi.org/10.24412/2687-0053-2026-1-15-21

References

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3): 209-249. doi: 10.3322/caac.21660

Zlokachestvennie novoobrazovaniya v Rossii v 2021 godu (zabolevaemost i smertnost) /pod red. Kaprina AD, Starinskogo VV, Shakhzadovoi AO. M.: MNIOI im. P.A. Gertsena, 2022. 252 s. Russian (Злокачественные новообразования в России в 2021 году (заболеваемость и смертность) /под ред. Каприна А.Д., Старинского В.В., Шахзадовой А.О. М.: МНИОИ им. П.А. Герцена, 2022. 252 с.)

Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK, et al. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021; 19(3): 329-359. doi: 10.6004/jnccn.2021.0012

Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953; 6(5): 963-968. doi: 10.1002/1097-0142(195309)6:5<963::aid-cncr2820060515>3.0.co;2-q

Rabeneck L, Chiu HM, Senore C. International Perspective on the Burden of Colorectal Cancer and Public Health Effects. Gastroenterology. 2020; 158(2): 447-452. doi: 10.1053/j.gastro.2019.10.007

Fridman WH, Miller IS, Sautès-Fridman C, Byrne AT. Therapeutic Targeting of the Colorectal Tumor Stroma. Gastroenterology. 2020; 158(2): 303-321. doi: 10.1053/j.gastro.2019.09.045

Kastrinos F, Samadder NJ, Burt RW. Use of Family History and Genetic Testing to Determine Risk of Colorectal Cancer. Gastroenterology. 2020; 158(2): 389-403. doi: 10.1053/j.gastro.2019.11.029

Yanus GA, Ievleva AG, Malygin AYu, Suspitsyn EN, Aleksakhina SN, Imyanitov EN. Monogenic Predisposition to Colorectal Cancer: Features of Carcinogenesis and Translational Aspects. Siberian Journal of Oncology. 2025; 24(5): 113-127. Russian (Янус Г.А., Иевлева А.Г., Малыгин А.Ю., Суспицын Е.Н., Алексахина С.Н., Имянитов Е.Н. Моногенная предрасположенность к развитию колоректального рака: особенности канцерогенеза и трансляционные аспекты //Сибирский онкологический журнал. 2025. Т. 24, № 5. С. 113-127.) doi: 10.21294/1814-4861-2025-24-5-113-127

Shtygashеva OV, Ageeva ES, Guzar YaR. Anamnestic Predictors of Colorectal Cancer. Experimental and Clinical Gastroenterology. 2019; (2): 50-54. Russian (Штыгашева О.В., Агеева Е.С., Гузарь Я.Р. Анамнестические предикторы колоректального рака. Экспериментальная и клиническая гастроэнтерология. 2019. № 2. С. 50-54.) doi: 10.31146/1682-8658-ecg-162-2-50-54

Song M, Chan AT, Sun J. Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer. Gastroenterology. 2020; 158: 322-340. doi: 10.1053/j.gastro.2019.06.048

Curtius K, Wong CJ, Hazelton WD, Kaz AM, Chak A, Willis JE, et al. A molecular clock infers heterogeneous tissue age among patients with Barrett’s esophagus. PLoS Comput Biol. 2021; 17(5): e1008969. doi: 10.1371/journal.pcbi.1004919

Lieberman D, Gupta S. Does Colon Polyp Surveillance Improve Patient Outcomes? Gastroenterology. 2020; 158(2): 436-440. doi: 10.1053/j.gastro.2019.10.008

Nguyen LH, Goel A, Chung DC. Pathways of Colorectal Carcinogenesis. Gastroenterology. 2020; 158(2): 291-302. doi: 10.1053/j.gastro.2019.08.059

Andreev DA, Kashchurinov AYu, Zavyalov AA. Colorectal cancer screening: foreign guidelines on fecal immunochemical test cut-off (review). Problems in Oncology. 2021; 67(4): 456-462. Russian (Андреев Д.А., Кашурников А.Ю., Завьялов А.А. Скрининг на колоректальный рак: пороговые концентрации гемоглобина в фекальном иммунохимическом тесте (обзор зарубежных рекомендаций) //Вопросы онкологии. 2021. Т. 67, № 4. С. 456-462.) doi: 10.37469/0507-3758-2021-67-4-456-462

Naumova LA. A Modern Perspective on the Concept of Field Cancerization. Vestnik SurGU. Meditsina. 2021; (2 (48)): 61-70. Russian (Наумова Л.А. Современный взгляд на концепцию полевой канцеризации //Вестник СурГУ. Медицина. 2021. № 2(48). С. 61-70.) doi: 10.34822/2304-9448-2021-2-61-70

Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. The Genetic Basis of Slaughter's «Field Cancerization» Concept: Evidence and Clinical Implications. Cancer Res. 2003; 63(8): 1727-1730

McSorley ST, Black DH., Horgan PG, McMillan, DC. The relationship between tumour stage, systemic inflammation, body composition and survival in patients with colorectal cancer. Clin Nutr. 2018; 37(4): 1279-1285. doi: 10.1016/j.clnu.2017.05.017

Downloads

Download data is not yet available.

Most read articles by the same author(s)